Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Up so far on a down market day, that’s nice to see!
How many is that now....4? How about dumping 2 of them?
Half way to $26.08!
Not after today!
Yes, expected at some detail on the actions required by ANI during the CC.
Instead, we got we are in process of requesting a type A meeting with FDA.
Not even long that will take. Very disappointed.
Dropped way too low on the panic. Last buy at .82 is looking good now!
Lakingsphan0427, Great upgrades. Thanks for the post.
Jtfm, Agree, I said the same thing. He had no other reason to say what he said about his shares. I think they kinda cut him off at the end though, it sounded bad.
Listen in on their CC today at 4:30.
Ya, never heard a CC like this with no questions at all, very strange. Maybe pre-determined Not to take calls? One interesting comment from Art, that he continues to be a long term shareholder.
Check out VGX 3100. That is more important to INO as far a their credibility is concerned.
Lexy is a "low floater" for sure at this point. Please share your Tech analysis after you are done.
I hear you on that. I am upset as well. As I stated before Chris still owes his shareholders a public follow up to his public statement about Altria. Even if the statement is, "at time we still do not have a response from Altria about our Phase 1 submission to them, from January.
You didn't really expect MO to announce something with Lexy in their CC? I listened and they didn't. They did talk a lot about their ON product and it seems to be going very well. Would be the best fit of their current products with DehydraTECH.
To me, that would be the only reason to delay some sort of announcement by Lexy. Still I would expect a PR fairly soon.
Agree, by tomorrow at the latest. Even if Altria does miss their deadline to Lexy, they (lexy) still should issue a statement, stating that. This is public knowledge since mid January.
Yeah they must have had a secret 4 person BOD meeting that got leaked! Nice to see a big up day.
Correction it was TP of $26.08!
Hey Thanks for that 11 Year Old Article!
Agent Smith; agree. If Lexy could partner with some mid size to big Pharma for the Canadian University studies on some type of current antiviral being tested as a Covid treatment, That would be significant!
Agree Stockman. From the interview with Bunka that I saw I think was in mid-January...Altria was obligated to respond in 90 days, per Chris. Times up I believe. At the latest April 30th.
My thoughts as well. Something stinks like fish!
Long? From last month? There is more under the hood with INO other than just the Covid vaccine.
Do you have a link for this news?
Thanks for the link Abundance. Good news on discussions with 3 Fortune 500 Pharma Co's. IMO a partnership deal with one or hopefully more is the key to future revenue and credibility. A funding deal will start to move the SP in the right direction. But remember it can take years for Pharma to study and test any new technology before it can be released.
Plus the testing will be costly to Lexy and will take time. Lexy needs a Pharma partner to team up with to defray costs and add credibility.
Thanks BB. From ER and CC coverage I have never seen Merrill Lynch with published coverage or attending. I see coverage from Raymond James, Cantor, Guggenheim, Concordia at the recent CC's. Maybe we see ML Initiate coverage on ANI? I have been expecting New analyst coverage of ANI as the result of the Corti filing.
Ya I'd like to see that. Maybe ML is buying now?
Trust me, most of my shares will be gone Before it hits $26.08!
Kinda my thought as well on Art leaving. IMO Art left on his own but it was of a result of a disagreement with the BOD. Not sure as the reasons, could have been disagreement about selling or merging the company and timeframe, or recent performance, (last 2-3 qtrs. have not been good vs expectations) or possibly LibiGel direction. Also feel Art was not the greatest spokesman for his Company. Just not his thing, but something I believe ANI/we need as we get ready to launch your biggest product, by far.
I own an follow GILD. I don't believe they have any effort underway at this point that I have read about, to make Remdesivir into pill form.
Or a random number like $26.08.
Thanks for sharing BB. Interesting, did ML offer a target price for ANI?
Also had they ever reported on ANI before this? I don't think I ever saw ANI coverage by ML.
Thanks Jtfm, that's what I thought from Art's comments. The Marketwatch article is wrong then and it was published this past January.
Brusselsspirit Thanks for the link. More of a market than I thought for IS,
139M in 2019. It also says in the article that the main 2 competitors Acthar Gel and Sabril both have Orphan Drug Exclusivity in the US.
Thanks JTFM. Most people (not on this site) still don't know that Corti is Not a generic. I have been on the MNK site before, if they even talk about ANI and Corti, it's always called a generic. But This guy from MF should know. Do you remember Art talking about IS annual market?
https://dashboard.stck.pro/news_hit.php?news_id=4289351 Interesting Article from MF. The author discounts revenue to ANI due to lack of infantile spasms covered under Corti now. Seems like I remember Art saying the market for IS was not very big? Later he mentioned that ANI would persue the IS indication at some future point.
I say $82.31!
Last year the 1st qtr ER CC was on 5/9. Art leaves 5/10. (Sunday) When is and who will run the CC?
LD, Agree with this now more than ever after the Art news. Hope it will be ABBV, I have owned them for a couple of years.